Diet supplementation with prebiotics to improve gut health in young Egyptian children
The Application of Potential Biotechnologies to Develop Novel Probiotics Functional Food Products With High Viability for Modulating the Gut Microbiome Among Healthy and Under Stress Subiects
This study tests if giving young Egyptian children biscuits with prebiotic fiber can improve their gut health and help protect them from diarrhea.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 3 Years to 6 Years |
| Sex | All |
| Sponsor | National Research Centre, Egypt Academic / other |
| Locations | 1 site (Dokki, Giza) |
| Trial ID | NCT06561724 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the impact of dietary supplementation with prebiotic fiber on the gut health of young Egyptian children, who are particularly susceptible to diarrhea. By providing biscuits containing prebiotics such as maltodextrin and inulin, the study seeks to enhance the gut microbiota, which plays a crucial role in nutrition, immunity, and overall health. The research will involve monitoring the children's gut health and microbial colonization over a specified period. The study is designed to address the high burden of gut infections in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 3 to 6 years who are healthy and whose mothers can comply with the research protocol.
Not a fit: Patients with gastrointestinal diseases, chronic conditions, or those who have taken antibiotics in the past three months may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved gut health and reduced incidence of diarrhea in young children.
How similar studies have performed: Other studies have shown promising results with prebiotic supplementation in improving gut health, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • The inclusion criteria were children aged ≥3 and below 6 years and the ability of the child's mother to comply with the research protocol and to collect the biological materials at predetermined dates. Exclusion Criteria: * gastrointestinal diseases * chronic diseases (such as type 1 diabetes) * intake of antibiotics within the previous 3 months.
Where this trial is running
Dokki, Giza
- Mosab Gad — Dokki, Giza, Egypt (Recruiting)
Study contacts
- Principal investigator: Laila Hussein, PhD — National Research Centre, Egypt
- Study coordinator: Mosab Gad, PhD
- Email: mg.gad@nrc.sci.eg
- Phone: 00201009855570
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.